Lineage Cell Therapeutics Inc LCTX:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.08quote price arrow up+0.02 (+1.89%)
Volume
13,212
Close
1.06quote price arrow up+0.01 (+0.95%)
Volume
597,092
52 week range
0.84 - 1.61
Loading...
  • Open1.09
  • Day High1.12
  • Day Low1.05
  • Prev Close1.05
  • 52 Week High1.61
  • 52 Week High Date03/28/24
  • 52 Week Low0.84
  • 52 Week Low Date02/01/24

Key Stats

  • Market Cap199.845M
  • Shares Out188.53M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-2.75

KEY STATS

  • Open1.09
  • Day High1.12
  • Day Low1.05
  • Prev Close1.05
  • 52 Week High1.61
  • 52 Week High Date03/28/24
  • 52 Week Low0.84
  • 52 Week Low Date02/01/24
  • Market Cap199.845M
  • Shares Out188.53M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-2.75

RATIOS/PROFITABILITY

  • EPS (TTM)-0.12
  • P/E (TTM)-8.53
  • Fwd P/E (NTM)-9.06
  • EBITDA (TTM)-24.041M
  • ROE (TTM)-31.42%
  • Revenue (TTM)8.945M
  • Gross Margin (TTM)92.50%
  • Net Margin (TTM)-240.12%
  • Debt To Equity (MRQ)0.23%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lineage Cell Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment...
Michael Mulroy J.D.
Independent Chairman of the Board
Brian Culley
Chief Executive Officer, Director
Jill Howe
Chief Financial Officer
George Samuel III
General Counsel, Corporate Secretary
Address
2173 Salk Ave Ste 200
Carlsbad, CA
92008-7354
United States

Top Peers

SYMBOLLASTCHG%CHG
CLLS
Cellectis SA
2.99UNCHUNCH
GBIO
Generation Bio Co
3.17+0.06+1.93%
MESO
Mesoblast Ltd
7.50+0.21+2.88%
PRQR
ProQR Therapeutics NV
2.01+0.02+1.01%
CRVO
CervoMed Inc
24.06-0.08-0.33%